XORTX Adds Banker Depesh Narotam as Independent Director
Image
Calgary – October 12, 2026 -- XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU) has appointed Depesh Narotam, a financial services executive with more than 20 years of experience, to its board as an independent director effective July 27, 2026.
Board determines Narotam meets Nasdaq and Canadian independence standards
The board determined that Narotam, 43, is independent under applicable Nasdaq listing standards and Canadian securities laws. He also joins the board's Compensation, Governance and Nominating Committee.
Narotam is a resident of British Columbia, Canada.